Other Prognastic Factors of The IDEA Collaboration
Afsaneh Barzi, M.D., discusses other prognastic factors of the IDEA collaboration.
Author: Annual-Meeting
Added: 08/21/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 22, 2019 Category: Cancer & Oncology Source Type: podcasts
The impact the IDEA data will have on clinicians
Afsaneh Barzi, M.D., discusses the impact the the IDEA data will have on clinicians today.
Author: Annual-Meeting
Added: 08/21/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 22, 2019 Category: Cancer & Oncology Source Type: podcasts
3 Vs. 6 months of Adjuvant for Stage 3 Colon Cancer
Afsaneh Barzi, M.D., discusses 3 months Vs. 6 months of Adjuvant for Colon Cancer.
Author: Annual-Meeting
Added: 08/21/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 22, 2019 Category: Cancer & Oncology Source Type: podcasts
IDEA Collaboration
Afsaneh Barzi, M.D., discusses the International Duration Evaluation of Adjuvant Chemotherapy.
Author: Annual-Meeting
Added: 08/21/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 22, 2019 Category: Cancer & Oncology Source Type: podcasts
Immediate Implications of the POLO study.
POLO trial for advanced pancreatic cancer: a new standard of care. Treatment with the drug olaparib significantly reduced the risk of disease progression or death from metastatic pancreatic cancer,
Author: Annual-Meeting
Added: 08/21/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 22, 2019 Category: Cancer & Oncology Source Type: podcasts
Unanswered questions after the POLO study
POLO trial for advanced pancreatic cancer: a new standard of care. Treatment with the drug olaparib significantly reduced the risk of disease progression or death from metastatic pancreatic cancer,
Author: Annual-Meeting
Added: 08/21/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 22, 2019 Category: Cancer & Oncology Source Type: podcasts
POLO Study
Maintenance therapy for BRCA mutants.
Author: Annual-Meeting
Added: 08/21/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 22, 2019 Category: Cancer & Oncology Source Type: podcasts
Taofeek Owonikoko, MD Discusses lurbinectedin as a Potential Practice Changing in SCLC Treatment
Lurbinectedin, a potential practice changing drug if approved, will be the only agent available in SCLC tested with immunotherapy. PharmaMar to submit New Drug Application (NDA) for lurbinectedin unde...
Author: PharmaMar
Added: 08/21/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 21, 2019 Category: Cancer & Oncology Source Type: podcasts
Pharmamar-Taofeek Owonikoko
Author: PharmaMar
Added: 08/21/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 21, 2019 Category: Cancer & Oncology Source Type: podcasts
Hossein Borghaei, MD discusses lurbinectedin recent data and advantages and potential limitations of the new drug
PharmaMar to submit New Drug Application (NDA) for lurbinectedin under accelerated approval in SCLC in the USA. Hossein Borghaei, MD discusses the recent data released and advantages and potential lim...
Author: PharmaMar
Added: 08/21/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 21, 2019 Category: Cancer & Oncology Source Type: podcasts
Hossein Borghaei, MD of Fox Chase Discusses new data on lurbinectedin
PharmaMar will submit New Drug Application (NDA) for lurbinectedin under accelerated approval in SCLC in the USA. Hossein Borghaei, MD of Fox Chase discusses the new data released and what advantages ...
Author: PharmaMar
Added: 08/21/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 21, 2019 Category: Cancer & Oncology Source Type: podcasts
Multiple Myeloma - What is the role of MRD in MM
Author: cancergrace
Added: 08/13/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 13, 2019 Category: Cancer & Oncology Source Type: podcasts
Multiple Myeloma - What are the novel new antibodies for MM therapy
Author: cancergrace
Added: 08/13/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 13, 2019 Category: Cancer & Oncology Source Type: podcasts
Multiple Myeloma - Should everyone receive an autologous transplant
Author: cancergrace
Added: 08/13/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 13, 2019 Category: Cancer & Oncology Source Type: podcasts
Multiple Myeloma - Is there a preferred induction therapy
Author: cancergrace
Added: 08/13/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 13, 2019 Category: Cancer & Oncology Source Type: podcasts
